ADC Therapeutics SA Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ADC Therapeutics SA quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2022 to Q4 2023.
  • ADC Therapeutics SA Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $212M, a 61.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $212M +$81M +61.7% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $131M Dec 31, 2022 10-K 2024-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.